Feb 07, 2025 / 01:30PM GMT
Operator
Hello, everyone, and welcome to the Iterum Therapeutics PLC Fourth-Quarter and Full Year 2024 Financial Results. My name is Ezra, and I will be your coordinator today. (Operator Instructions) I will now hand you over to Louise Barrett, Senior Vice President, Legal Affairs, to begin. Louise, please go ahead.
Louise Barrett - Iterum Therapeutics PLC - Senior Vice President, Legal Affairs
Thank you Ezra. Good morning and welcome to Interim Therapeutics Fourth-Quarter and Full Year 2024 Financial Results and Business Update Conference Call. A press release with our fourth-quarter and full year results was issued earlier this morning and can be found on our website. We are joined this morning by our Chief Executive Officer, Corey Fishman, and Chief Financial Officer, Judith Matthews. Corey will provide some opening remarks, Judith will provide details on our financial results, and then we'll open the lines to Q&A.
Before we begin. I'd like to remind you that some of the information presented on this conference call will contain forward-looking statements
Q4 2024 Iterum Therapeutics PLC Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
